Ideaya Biosciences Inc
IDYA
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.17B
Close$
$-1.63
104.8% downside
Current Fair Value
104.8% downsideOvervalued by 104.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.17 Billion |
|---|---|
| Enterprise Value | $2.93 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.28 |
| Beta | -0.09 |
| Outstanding Shares | 92,061,452 |
Return
| Return on Equity | -14.60% |
|---|---|
| Return on Assets | -13.36% |
| Return on Invested Capital | -16.97% |
Valuation & Multiples
| P/E Ratio | -17.11 |
|---|---|
| PEG | -37.92 |
| Price to Sales | 16.91 |
| Price to Book Ratio | 2.6 |
| Enterprise Value to Revenue | 12.5 |
| Enterprise Value to EBIT | -14.05 |
| Enterprise Value to Net Income | -17 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-1.06
Average shareholder expectationRevenue Estimate
$8.02 M
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-1.18
Average shareholder expectationRevenue Estimate
$9.92 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 70.28% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.35%▼ 111.56% |
|---|---|
| Total Invested | $12.45M▼ 99.68% |
| Investors Holding | 19▼ 275.00% |
ESG Score
No data
About Ideaya Biosciences Inc
CEO: Yujiro Hata